K. Cerchio

716 total citations
13 papers, 550 citations indexed

About

K. Cerchio is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cognitive Neuroscience. According to data from OpenAlex, K. Cerchio has authored 13 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cognitive Neuroscience. Recurrent topics in K. Cerchio's work include Growth Hormone and Insulin-like Growth Factors (6 papers), Sleep and Wakefulness Research (3 papers) and Cancer therapeutics and mechanisms (2 papers). K. Cerchio is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (6 papers), Sleep and Wakefulness Research (3 papers) and Cancer therapeutics and mechanisms (2 papers). K. Cerchio collaborates with scholars based in United States, Sweden and United Kingdom. K. Cerchio's co-authors include M. Gail Murphy, David Krupa, Keith Gottesdiener, Gail Murphy, William J. Polvino, S. Aubrey Stoch, R. R. Recker, Mei Wu, Johan Svensson and B. J. Gertz and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and Psychopharmacology.

In The Last Decade

K. Cerchio

13 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Cerchio United States 12 211 203 193 147 95 13 550
Shogo Oki Japan 15 108 0.5× 130 0.6× 222 1.2× 327 2.2× 23 0.2× 44 734
Davelene D. Israel United States 10 147 0.7× 84 0.4× 36 0.2× 99 0.7× 38 0.4× 10 506
Sylvain Contié France 4 195 0.9× 76 0.4× 31 0.2× 85 0.6× 51 0.5× 4 333
M. Lubin United States 5 50 0.2× 206 1.0× 342 1.8× 122 0.8× 19 0.2× 7 555
Grace W.C. Cheung Canada 11 289 1.4× 358 1.8× 199 1.0× 346 2.4× 69 0.7× 16 938
Jean‐Pierre Max France 14 289 1.4× 138 0.7× 80 0.4× 84 0.6× 15 0.2× 28 653
Peter K. Davidsen United Kingdom 8 80 0.4× 183 0.9× 27 0.1× 310 2.1× 9 0.1× 9 587
V. Lenoir France 13 62 0.3× 64 0.3× 98 0.5× 90 0.6× 29 0.3× 24 409
Gabriel Sturm United States 11 46 0.2× 102 0.5× 32 0.2× 222 1.5× 19 0.2× 16 470
Jun‐Ge Yu United States 12 57 0.3× 127 0.6× 19 0.1× 142 1.0× 53 0.6× 17 495

Countries citing papers authored by K. Cerchio

Since Specialization
Citations

This map shows the geographic impact of K. Cerchio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Cerchio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Cerchio more than expected).

Fields of papers citing papers by K. Cerchio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Cerchio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Cerchio. The network helps show where K. Cerchio may publish in the future.

Co-authorship network of co-authors of K. Cerchio

This figure shows the co-authorship network connecting the top 25 collaborators of K. Cerchio. A scholar is included among the top collaborators of K. Cerchio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Cerchio. K. Cerchio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bohórquez, Sandra Sanabria, David Mozley, Donald Burns, et al.. (2013). 11C-MK-8278 PET as a Tool for Pharmacodynamic Brain Occupancy of Histamine 3 Receptor Inverse Agonists. Journal of Nuclear Medicine. 55(1). 65–72. 20 indexed citations
2.
Lush, Richard M., Amita Patnaik, Daniel M. Sullivan, et al.. (2012). A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 70(4). 567–574. 1 indexed citations
3.
Iannone, Robert, John Palcza, John J. Renger, et al.. (2011). Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers. Psychopharmacology. 215(4). 643–653. 33 indexed citations
4.
Iannone, Raffaele, John Palcza, John J. Renger, et al.. (2010). Acute Alertness-Promoting Effects of a Novel Histamine Subtype-3 Receptor Inverse Agonist in Healthy Sleep-Deprived Male Volunteers. Clinical Pharmacology & Therapeutics. 88(6). 831–839. 26 indexed citations
5.
Boyle, Julia, et al.. (2008). Next‐day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double‐blind study in healthy elderly subjects. Human Psychopharmacology Clinical and Experimental. 24(1). 61–71. 13 indexed citations
6.
Murphy, M. Gail, K. Cerchio, S. Aubrey Stoch, et al.. (2005). Effect of L-000845704, an αVβ3 Integrin Antagonist, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women. The Journal of Clinical Endocrinology & Metabolism. 90(4). 2022–2028. 98 indexed citations
7.
Murphy, M. Gail, Michael R. McClung, Thomas J. Schnitzer, et al.. (2001). Effect of Alendronate and MK-677 (a Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women1. The Journal of Clinical Endocrinology & Metabolism. 86(3). 1116–1125. 67 indexed citations
8.
Codner, Ethel, Fernando Cassorla, Anatoly Tiulpakov, et al.. (2001). Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone–insulin‐like growth factor I axis in growth hormone–deficient children. Clinical Pharmacology & Therapeutics. 70(1). 91–98. 27 indexed citations
9.
Murphy, M. Gail, Mark A. Bach, D. Plotkin, et al.. (1999). Oral Administration of the Growth Hormone Secretagogue MK-677 Increases Markers of Bone Turnover in Healthy and Functionally Impaired Elderly Adults. Journal of Bone and Mineral Research. 14(7). 1182–1188. 39 indexed citations
10.
Svensson, Johan, Lars Lönn, John‐Olov Jansson, et al.. (1998). Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure1. The Journal of Clinical Endocrinology & Metabolism. 83(2). 362–369. 125 indexed citations
11.
Svensson, Johan, Claes Ohlsson, John‐Olov Jansson, et al.. (1998). Treatment with the Oral Growth Hormone Secretagogue MK-677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males. Journal of Bone and Mineral Research. 13(7). 1158–1166. 30 indexed citations
12.
Chapman, Ian, Ora Hirsch Pescovitz, Gail Murphy, et al.. (1997). Oral Administration of Growth Hormone (GH) Releasing Peptide-Mimetic MK-677 Stimulates the GH/Insulin-Like Growth Factor-I Axis in Selected GH-Deficient Adults1. The Journal of Clinical Endocrinology & Metabolism. 82(10). 3455–3463. 49 indexed citations
13.
Polvino, William J., David Sciberras, K. Cerchio, et al.. (1996). PHARMACOKINETICS AND FOOD INTERACTION OF MK-462 IN HEALTHY MALES. Biopharmaceutics & Drug Disposition. 17(1). 17–24. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shogo Oki Breakdown of academic impact, for papers by Davelene D. Israel Breakdown of academic impact, for papers by Sylvain Contié Breakdown of academic impact, for papers by M. Lubin Breakdown of academic impact, for papers by Grace W.C. Cheung Breakdown of academic impact, for papers by Jean‐Pierre Max Breakdown of academic impact, for papers by Peter K. Davidsen Breakdown of academic impact, for papers by V. Lenoir Breakdown of academic impact, for papers by Gabriel Sturm Breakdown of academic impact, for papers by Jun‐Ge Yu
Rankless by CCL
2026